These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13304353)

  • 1. Effect of added toxoids on the antigenicity of H. pertussis vaccines.
    UNGAR J
    Br Med J; 1956 Apr; 1(4971):841-2. PubMed ID: 13304353
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of methods for assessing the antigenic response to pertussis vaccine.
    TAYLOR EM; MOLONEY PJ; REID DB
    Can J Microbiol; 1956 Apr; 2(2):94-101. PubMed ID: 13316603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the immunogenic effect of pertussis vaccines].
    JOO I; CSIZMAS L
    Gyermekgyogyaszat; 1956 Jan; 7(1):1-10. PubMed ID: 13294618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-whooping cough vaccine prepared by various methods; experiments on mice].
    IKIC D; BENKOVIC J
    Acta Med Iugosl; 1955; 9(1):46-53. PubMed ID: 13301369
    [No Abstract]   [Full Text] [Related]  

  • 5. Littermate assays of pertussis vaccine.
    IRWIN JO; STANDFAST AF
    J Hyg (Lond); 1955 Mar; 53(1):106-11. PubMed ID: 14367807
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in whooping-cough agglutinins in mice after simultaneous injection of hyper-immune serum and whooping-cough vaccine].
    BOAKE WC; LEVY FM
    C R Seances Soc Biol Fil; 1956 May; 150(1):83-6. PubMed ID: 13330290
    [No Abstract]   [Full Text] [Related]  

  • 9. Histamine-sensitizing activity of various pertussis vaccines.
    JOO I; PUSZTAI Z; JUHASZ VP
    Z Immun exp ther; 1961 Mar; 121():143-58. PubMed ID: 13790657
    [No Abstract]   [Full Text] [Related]  

  • 10. The epidemiological evaluation of a non-cellular pertussis antigen.
    FELTON HM; VERWEY WF
    Pediatrics; 1955 Nov; 16(5):637-51. PubMed ID: 13273100
    [No Abstract]   [Full Text] [Related]  

  • 11. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cow's blood in Bordet-Gengou medium for pertussis vaccine preparation.
    LIN TM; LIU CH; HSHU CP
    Appl Microbiol; 1956 Mar; 4(2):107-8. PubMed ID: 13303144
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative investigations into the mouse-protective potency, histamine-sensitizing activity and agglutinin-producing ability of pertussis vaccines.
    JOO I; PUSZTAI Z; JUHASZ VP
    Z Immun exp ther; 1961 May; 121():250-66. PubMed ID: 13790655
    [No Abstract]   [Full Text] [Related]  

  • 15. A NEW APPROACH TO BACTERIAL VACCINES.
    GREENBERG L
    Can Med Assoc J; 1963 Aug; 89(9):396-402. PubMed ID: 14042791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of both interference and antibody immunity by pertussis vaccine to pertussis infection in mice.
    EVANS DG; PERKINS FT
    Br J Exp Pathol; 1955 Aug; 36(4):391-401. PubMed ID: 13250115
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
    Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic characteristics of pertussis microbe. III. Whooping cough anatoxin; combined whooping cough vaccine].
    TRUSHINA-TUMANOVA EF
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jul; 27(7):59-64. PubMed ID: 13353721
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation between agglutinin production by pertussis vaccines and their immunising potency in mice.
    PRESTON NW; TE PUNGA WA
    J Pathol Bacteriol; 1959 Jul; 78():209-16. PubMed ID: 14434791
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.